T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.95% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 12.8% |
| 4 | Industrials | 12.27% |
| 5 | Technology | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
CorVel
CRVL
$3.26B
| $9.52M | ﹤0.01% |
632,298
+64,500
| +11% | +$1.01M |
|
1327
Insulet
PODD
$10B
| $9.48M | ﹤0.01% |
238,976
-731,953
| -75% | -$28.1M |
|
1328
Ascent Industries
ACNT
$133M
| $9.41M | ﹤0.01% |
572,976
+5,100
| +0.9% | +$79.2K |
|
|
LTM
1329
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
| $9.41M | ﹤0.01% |
701,032
-107,611
| -13% | -$1.58M |
|
1330
Pitney Bowes
PBI
$2.26B
| $9.34M | ﹤0.01% |
338,281
+40,300
| +14% | +$1.07M |
|
1331
Rollins
ROL
$17.4B
| $9.3M | ﹤0.01% |
1,046,645
+99,563
| +11% | +$894K |
|
1332
Darden Restaurants
DRI
$25.5B
| $9.19M | ﹤0.01% |
222,119
-3,252
| -1% | -$144K |
|
|
RNWK
1333
DELISTED
RealNetworks Inc
RNWK
| $9.1M | ﹤0.01% |
1,193,211
-149,215
| -11% | -$1.13M |
|
|
FTR
1334
DELISTED
Frontier Communications Corp.
FTR
| $9.08M | ﹤0.01% |
103,643
-14,454
| -12% | -$1.25M |
|
|
FCRD
1335
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $9.04M | ﹤0.01% |
645,920
+30,560
| +5% | +$412K |
|
1336
O-I Glass
OI
$1.04B
| $8.91M | ﹤0.01% |
257,230
| – | – |
|
1337
Royal Caribbean
RCL
$82.8B
| $8.89M | ﹤0.01% |
159,960
-16,402
| -9% | -$883K |
|
|
SFLY
1338
DELISTED
Shutterfly, Inc.
SFLY
| $8.85M | ﹤0.01% |
205,500
+8,300
| +4% | +$340K |
|
|
AMAG
1339
DELISTED
AMAG Pharmaceuticals
AMAG
| $8.81M | ﹤0.01% |
425,220
-995,900
| -70% | -$18.4M |
|
|
AIV
1340
Aimco
AIV
$381M
| $8.76M | ﹤0.01% |
2,038,600
| – | – |
|
|
ANSS
1341
DELISTED
Ansys
ANSS
| $8.6M | ﹤0.01% |
113,365
-143,997
| -56% | -$10.8M |
|
|
CRZO
1342
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $8.55M | ﹤0.01% |
123,500
+113,500
| +1,135% | +$6.58M |
|
1343
Dick's Sporting Goods
DKS
$18.1B
| $8.55M | ﹤0.01% |
183,591
+289
| +0.2% | +$14.1K |
|
1344
Stepan Co
SCL
$1.47B
| $8.53M | ﹤0.01% |
161,338
+4,400
| +3% | +$247K |
|
|
FCE.A
1345
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $8.39M | ﹤0.01% |
422,330
-219,500
| -34% | -$4.19M |
|
1346
Toll Brothers
TOL
$13.9B
| $8.33M | ﹤0.01% |
225,820
+5,000
| +2% | +$177K |
|
|
RKT
1347
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $8.33M | ﹤0.01% |
157,754
+11,530
| +8% | +$581K |
|
|
TDAY
1348
USA Today Co
TDAY
$1B
| $8.29M | ﹤0.01% |
587,305
-595,226
| -50% | -$8.48M |
|
1349
Ziff Davis
ZD
$1.89B
| $8.27M | ﹤0.01% |
186,875
+16,905
| +10% | +$706K |
|
1350
Avery Dennison
AVY
$13.5B
| $8.23M | ﹤0.01% |
160,616
+1,510
| +0.9% | +$74.9K |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.